Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

Haruka Koizumi, Atsushi Tokuriki, Noritaka Oyama, Hideki Ido, Kazumitsu Sugiura, Masashi Akiyama, Minoru Hasegawa

Research output: Contribution to journal › Letter

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)723-724
Number of pages2
JournalJournal of Dermatology
Volume44
Issue number6
DOIs
Publication statusPublished - 01-06-2017

Fingerprint

Psoriasis
Rheumatoid Arthritis
Tumor Necrosis Factor-alpha
Certolizumab Pegol

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Koizumi, Haruka ; Tokuriki, Atsushi ; Oyama, Noritaka ; Ido, Hideki ; Sugiura, Kazumitsu ; Akiyama, Masashi ; Hasegawa, Minoru. / Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis. In: Journal of Dermatology. 2017 ; Vol. 44, No. 6. pp. 723-724.
@article{a7caa46063de46359a04973b6c1d21cf,
title = "Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis",
author = "Haruka Koizumi and Atsushi Tokuriki and Noritaka Oyama and Hideki Ido and Kazumitsu Sugiura and Masashi Akiyama and Minoru Hasegawa",
year = "2017",
month = "6",
day = "1",
doi = "10.1111/1346-8138.13530",
language = "English",
volume = "44",
pages = "723--724",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "6",

}

Koizumi, H, Tokuriki, A, Oyama, N, Ido, H, Sugiura, K, Akiyama, M & Hasegawa, M 2017, 'Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis', Journal of Dermatology, vol. 44, no. 6, pp. 723-724. https://doi.org/10.1111/1346-8138.13530

Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis. / Koizumi, Haruka; Tokuriki, Atsushi; Oyama, Noritaka; Ido, Hideki; Sugiura, Kazumitsu; Akiyama, Masashi; Hasegawa, Minoru.

In: Journal of Dermatology, Vol. 44, No. 6, 01.06.2017, p. 723-724.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

AU - Koizumi, Haruka

AU - Tokuriki, Atsushi

AU - Oyama, Noritaka

AU - Ido, Hideki

AU - Sugiura, Kazumitsu

AU - Akiyama, Masashi

AU - Hasegawa, Minoru

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=84986275141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986275141&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.13530

DO - 10.1111/1346-8138.13530

M3 - Letter

VL - 44

SP - 723

EP - 724

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 6

ER -

Koizumi H, Tokuriki A, Oyama N, Ido H, Sugiura K, Akiyama M et al. Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis. Journal of Dermatology. 2017 Jun 1;44(6):723-724. https://doi.org/10.1111/1346-8138.13530

Access to Document